What is the management approach for a hemodialysis (HD) patient experiencing back pain during dialysis sessions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Back Pain During Hemodialysis

For a hemodialysis patient with back pain during dialysis sessions over the past 4 treatments, immediately assess for infective spondylodiscitis with MRI and blood cultures, while simultaneously evaluating for vascular access infection, as this represents a potentially life-threatening complication that requires urgent intervention. 1, 2

Immediate Diagnostic Evaluation

Rule Out Serious Infections First

  • Obtain non-contrast MRI of the spine urgently to evaluate for spondylodiscitis, which is a critical diagnosis in HD patients presenting with back pain, particularly when symptoms persist across multiple sessions 1, 2
  • Check inflammatory markers including C-reactive protein (elevated in 99.4% of HD patients with spondylodiscitis), erythrocyte sedimentation rate (elevated in 78.6%), and complete blood count for leukocytosis (present in 38.9%) 2
  • Obtain blood cultures before initiating antibiotics, as Staphylococci are the most common pathogen (38.9% of cases) in HD-associated spondylodiscitis 2
  • Examine the vascular access site meticulously for signs of infection, as 22.2% of spondylodiscitis cases in HD patients are associated with vascular access infections 2

Critical Red Flags Requiring Urgent Action

  • Back pain accompanied by fever strongly suggests spondylodiscitis and mandates immediate MRI 1
  • New neurological symptoms (weakness, numbness, bowel/bladder dysfunction) require emergency surgical consultation 1
  • Patients who started hemodialysis within the past year are at particularly high risk (44.4% of spondylodiscitis cases occur in this group) 2

Assess for Musculoskeletal and Metabolic Causes

Physical Examination Findings

  • Evaluate balance using the Tinetti scale, as 75.7% of HD patients with low back pain have balance disorders 3
  • Test quadriceps muscle strength using manual testing and Kendall scale, since 59.5% of HD patients with back pain demonstrate muscular weakness 3
  • Assess for bone disease manifestations, as this is strongly associated with chronic low back pain (OR: 43.39) 3

Risk Factor Assessment

  • Longer dialysis vintage increases back pain risk—patients with pain typically have been on dialysis for 4 years versus 3 years in those without pain 3, 4
  • Check for comorbidities including hypertension (OR: 4.51 for back pain), cerebrovascular disease (OR: 20.21), arterial hypertension, and coronary artery disease 3, 2
  • Evaluate residual renal function, as patients without RRF have higher pain incidence 4

Determine Pain Characteristics

Pain Assessment Tools

  • Use the McGill Pain Questionnaire to characterize pain type and severity 4
  • Apply the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scale, as 61.8% of HD patients with pain have neuropathic character 4
  • Document pain location—lower extremities and lumbar region are most common sites in HD patients 4, 2

Important Clinical Context

  • 74.4% of HD patients experience pain, yet only 36.4% receive analgesics, indicating systematic undertreatment 4
  • Pain is more common in females and increases with age 4
  • The lumbar region is affected in 77.8% of spondylodiscitis cases 2

Treatment Algorithm

If Spondylodiscitis is Confirmed or Highly Suspected

  • Initiate empirical antibiotic therapy immediately—do not delay for culture results 1
  • Arrange prompt surgical decompression if neurological compromise is present or imminent, as early surgery produces good outcomes 1
  • Monitor for abscess formation (occurs in 44.4% of cases) which may require drainage 2
  • Be aware that mortality rate is 16.7%, all deaths due to sepsis, and 33% of survivors have recurrence within 1 year 2

For Non-Infectious Chronic Back Pain

First-Line Non-Pharmacologic Interventions

  • Prescribe structured exercise programs, as moderate-quality evidence shows aerobic exercise reduces symptom burden in hemodialysis patients 5
  • Implement physical therapy focused on balance training and muscle strengthening to address the balance deficits (OR: 9.30) and muscular weakness (OR: 14.33) strongly associated with back pain 3
  • Consider cognitive behavioral therapy, which has demonstrated efficacy in reducing depression and pain perception in dialysis patients 5
  • Offer manual acupressure, which has short-term benefits as an adjuvant intervention 5
  • Utilize music therapy during dialysis sessions, as evidence indicates it can reduce pain perception 5

Pharmacologic Management When Non-Pharmacologic Measures Are Insufficient

  • For neuropathic pain (present in 61.8% of cases), use gabapentin or pregabalin as first-line agents 4, 6
  • Follow the WHO three-step analgesic ladder: start with non-opioids, then add weak opioids, then strong opioids if needed 6
  • For ESRD patients requiring opioids, methadone, fentanyl, and buprenorphine are the ideal choices due to favorable pharmacokinetics in renal failure 6
  • Alternative opioids include tramadol, oxycodone, and hydromorphone 6
  • Complex pain syndromes require multidrug regimens comprising opioids, non-opioids, and adjuvant medications individualized to achieve adequate control 6

Dialysis-Specific Modifications

Address Potential Dialysis-Related Factors

  • Review ultrafiltration rates and dry weight assessment, as rapid fluid removal can cause musculoskeletal discomfort 7
  • Evaluate for intradialytic hypotension or electrolyte shifts that may exacerbate pain 7
  • Consider whether positioning during dialysis contributes to discomfort and adjust accordingly 5

Critical Pitfalls to Avoid

  • Never dismiss persistent back pain in HD patients as "just musculoskeletal"—infective spondylodiscitis carries 16.7% mortality and requires urgent diagnosis 2
  • Do not wait for positive blood cultures to initiate treatment for suspected spondylodiscitis, as early negative cultures are common 1
  • Avoid undertreatment of pain—recognize that 74.4% of HD patients have pain but only 36.4% receive analgesics 4
  • Do not overlook vascular access as a source of infection leading to spondylodiscitis 2
  • Age alone should not influence treatment decisions, as it is not a predictive factor for outcomes in spondylodiscitis 1

Ongoing Management

  • Regularly assess pain symptoms at each dialysis session to improve quality of life, as pain is associated with increased depression and disrupted QOL 4
  • Monitor and preserve residual renal function when present, as its loss correlates with increased pain incidence 4
  • Involve palliative care consultation for complex pain management 6
  • Provide patient and family counseling about pain management options 6

References

Research

Spondylodiscitis in patients under haemodyalisis.

International orthopaedics, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of pain in end-stage renal disease patients: Short review.

Hemodialysis international. International Symposium on Home Hemodialysis, 2018

Guideline

Management of Intradialytic Chest Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.